Pelage Pharma: Funding, Investors & Team (Oct 2026)
Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.
Pelage Pharma has raised $151M across 3 funding rounds on record, the most recent a Series B of $120M announced in Oct 2025.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Pelage Pharma Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Pelage Pharma Funding Rounds
Pelage Pharma raised $16.8M in a Series A announced in Feb 2024.
6 months later, a Series A of $14.0M was announced in Aug 2024.
1.2 years later, a Series B of $120M was announced in Oct 2025.
Pelage Pharma Founders and Leadership Team
Contact details for the Pelage Pharma team: 2 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Pelage Pharma Funding Compared to Other Health Care Startups
Pelage Pharma's latest round of $120M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pelage Pharma in Health Care and Los Angeles
Companies Similar to Pelage Pharma
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Pelage Pharma Funding FAQs
What does Pelage Pharma do?
Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.
How much funding has Pelage Pharma raised?
Pelage Pharma has raised $151M across 3 rounds on record. The most recent is a Series B of $120M announced in Oct 2025.
When did Pelage Pharma last raise funding?
Pelage Pharma's most recent funding round on record is a Series B of $120M, announced in Oct 2025.
Who founded Pelage Pharma?
FundedIQ lists Heather Christofk (Founder), William Lowry (Founder) at Pelage Pharma.
Who is the CEO of Pelage Pharma?
Daniel Gil is listed as CEO at Pelage Pharma.
Where is Pelage Pharma headquartered?
Pelage Pharma is based in Los Angeles, California, United States.
How many employees does Pelage Pharma have?
Pelage Pharma is in the 1-10 employee band.
How does Pelage Pharma's funding compare to other Health Care startups?
Pelage Pharma's latest round of $120M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Pelage Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pelage Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.